Following AstraZeneca’s side effects, concerns arise over adverse events in some Covaxin recipients

A recent study on the Covaxin side effects of the Covid-19 vaccine by Bharat Biotech, which was common in India during the pandemic, has been illuminated. A research paper in SpringerLink showed that about a third of individuals who gave feedback had experienced adverse events of special interest (AESIs) after they received the shot. Such as Astrazeneca’s acknowledgement of side effects that are related to the Covishield vaccine.

Insights into Covaxin’s Adverse Effects: Findings from Banaras Hindu University Research

Researchers at Banaras Hindu University, led by Sankha Shubhra Chakrabarti, have contributed to research on Covaxin’s adverse symptoms. They were found to have a high risk of adverse events of special interest (AESI) based on the profiles of women with certain medical histories and people with allergies who received Covaxin.

The study group consisted of 1,024 adolescents and 291 adults. From the start, only 635 adolescents and 291 adults could have their progress tracked for a year.

Within these timeframes, individuals, both adults and adolescents, reported viral upper respiratory tract infections as vaccine-related events to Covaxin. Adolescents also reported episodes of new skin and subcutaneous disorders, general disorders, as well as nervous disorders, as adverse events after receiving the Covaxin vaccine. Additionally, in a similar manner, adults were frequently seen reporting general disorders, musculoskeletal problems, and nervous system disorders as a consequence of vaccinations.

The female participants complained of irregular periods, and while a lesser number complained of ocular disorders, hypothyroidism was also reported. Additionally, a few incidents experienced very serious adverse events of special interest (AESIs), such as stroke or Guillain-Barre syndrome.

The article highlighted the fact that teenagers, females, and those with a history of allergies or previous typhoid vaccination had a higher likelihood of getting AESIs, which are classified as adverse effects of concern.

However, some specified groups, such as those who were ill, usually had a higher risk of chronic AE. The analysis stressed the imperative of continuous nudging of individuals to report the progress and consequences of adverse events related to the vaccines.

Investigators essentially presented the need for careful monitoring, especially for individuals who had taken COVID-19 prior to vaccination and those who had pre-existing health problems.

The study revealed that the types of adverse events that took place post-Covid vaccination were totally different from those occurring after witnessing an adverse event of the Covishield vaccine. In addition to these, the trends are likely to differ across age groups, thus making the determination of post-vaccination adverse event development a grotesque task.

According to MoHFW, which is a ministry of the Ministry of Health and Family Welfare of the Indian government, the major side effects of the vaccine are fever, headaches, irritability, pain, swelling, and the combination of these signs, which can appear at the injected sites.

Other potential side effects listed by the Indian government’s Ministry of Health and Family Welfare (MoHFW) include trouble breathing, heartbeat acceleration, body rash formation, dizzy spells, and weakness.

You might also be interested in – Doctors urge government to review side effects of Covishield and all Covid vaccines